These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7692019)

  • 1. Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model.
    Nagata K; Sasaki T; Iwama J; Mori T; Iwamoto S; Nirei H; Hamada K; Kirino T
    J Neurosurg; 1993 Nov; 79(5):710-5. PubMed ID: 7692019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage.
    Nishizawa S; Peterson JW; Shimoyama I; Iwasaki K; Uemura K
    Neurosurgery; 1993 Jun; 32(6):986-91; discussion 991-2. PubMed ID: 7687044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK-506: a new immunosuppressive agent, failed to reduce cerebral vasospasm after experimental subarachnoid hemorrhage.
    Mori T; Nagata K; Ishida T; Sasaki T; Nirei H; Hamada K; Ohami H; Kirino T
    J Vet Med Sci; 1993 Aug; 55(4):581-6. PubMed ID: 7691190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs.
    Peterson JW; Nishizawa S; Hackett JD; Bun T; Teramura A; Zervas NT
    Stroke; 1990 Jan; 21(1):133-7. PubMed ID: 2300980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral vasospasm and lipoperoxide damage--morphological localization and measurement of lipoperoxide in prolonged cerebral vasospasm].
    Tokoro K
    No Shinkei Geka; 1984 Aug; 12(9):1049-58. PubMed ID: 6390241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal profile and significance of metabolic failure and trophic changes in the canine cerebral arteries during chronic vasospasm after subarachnoid hemorrhage.
    Yoshimoto Y; Kim P; Sasaki T; Takakura K
    J Neurosurg; 1993 May; 78(5):807-12. PubMed ID: 8468611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tissue plasminogen activator (t-PA) on cerebral vasospasm in canine subarachnoid hemorrhage.
    Chung WY; Lee LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Nov; 52(5):298-306. PubMed ID: 8299025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage.
    Osuka K; Suzuki Y; Tanazawa T; Hattori K; Yamamoto N; Takayasu M; Shibuya M; Yoshida J
    Acta Neurochir (Wien); 1998; 140(9):943-51. PubMed ID: 9842432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomechanical and phenotypic changes in the vasospastic canine basilar artery after subarachnoid hemorrhage.
    Yamaguchi-Okada M; Nishizawa S; Koide M; Nonaka Y
    J Appl Physiol (1985); 2005 Nov; 99(5):2045-52. PubMed ID: 16051708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
    Yanamoto H; Kikuchi H; Okamoto S
    Surg Neurol; 1994 Nov; 42(5):382-7. PubMed ID: 7974141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cerebral vasospasm by actinomycin D.
    Shigeno T; Mima T; Yanagisawa M; Saito A; Goto K; Yamashita K; Takenouchi T; Matsuura N; Yamasaki Y; Yamada K
    J Neurosurg; 1991 Jun; 74(6):940-3. PubMed ID: 2033454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
    J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calmodulin antagonist trifluoperazine provides mild prophylactic protection against cerebral vasospasm after subarachnoid hemorrhage, but no therapeutic value.
    Peterson JW; Candia G; Spanos AJ; Zervas NT
    Neurosurgery; 1989 Dec; 25(6):917-22. PubMed ID: 2601822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys.
    Macdonald RL; Weir BK; Young JD; Grace MG
    J Neurosurg; 1992 Jan; 76(1):81-90. PubMed ID: 1727173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of vasospasm and intracranial metabolism under experimental subarachnoid hemorrhage--Part 1. In reference with the acid-base-balance of cerebral blood and cerebrospinal fluid].
    Takahashi S
    No To Shinkei; 1978 Jul; 30(7):777-87. PubMed ID: 28740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein synthesis and immunoreactivities of contraction-related proteins in smooth muscle cells of canine basilar artery after experimental subarachnoid hemorrhage.
    Oka Y; Ohta S; Todo H; Kohno K; Kumon Y; Sakaki S
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1335-44. PubMed ID: 8898709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 of canine basilar artery in vasospasm.
    Yamaura I; Tani E; Maeda Y; Minami N; Shindo H
    J Neurosurg; 1992 Jan; 76(1):99-105. PubMed ID: 1727175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of prazosin hydrochloride on cerebral vasospasm--an experimental study].
    Ishibashi Y; Konda R; Yoshimoto T; Suzuki J
    No Shinkei Geka; 1984 Feb; 12(2):133-9. PubMed ID: 6717739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880.
    Hirashima Y; Endo S; Kato R; Takaku A
    J Neurosurg; 1996 May; 84(5):826-30. PubMed ID: 8622157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.